This is a prospective, randomized, double-blind, placebo-controlled pilot study to
investigate whether supplemental Nitric Oxide (NO) gas delivered during cardiac surgery with
cardiopulmonary bypass (CPB) reduces the incidence and impact of acute kidney injury (AKI) in
neonates undergoing surgery for congenital heart disease (CHD), when compared to placebo gas